COVID-19 Serological Survey-3 Prior to Second Wave in Mumbai, India
- PMID: 35368471
- PMCID: PMC8971881
- DOI: 10.4103/ijcm.ijcm_984_21
COVID-19 Serological Survey-3 Prior to Second Wave in Mumbai, India
Abstract
Background: Subsequent to serosurveys 1 and 2 for COVID-19 carried out in three wards of Mumbai in July and August 2020, Municipal Corporation of Greater Mumbai conducted serosurvey 3 in March 2021. This was to identify the extent of exposure by testing specific IgG antibodies against COVID-19.
Material and methods: A cross-sectional study was conducted to find the prevalence of seropositivity in Mumbai, which included 10,197 samples belonging to patients visiting public dispensaries (slum population, 6006) and private (nonslum population, 4191) laboratories of Aapli Chikitsa network for blood investigations for non-COVID illnesses. The ward-wise number of unlinked anonymous samples from 24 wards was predecided by using probability proportionate sampling. The samples were collected using quota sampling technique as per predecided sample for each ward. These samples collected from nonimmunized individuals were tested for IgG antibodies at the Molecular Biology Laboratory of Kasturba Hospital for Infectious Diseases by chemiluminescence assay (CLIA) method.
Results: The overall seropositivity was found to be 36.3% (41.6% in slum and 28.59% in nonslum population). It was more in city wards (38.28%) followed by western suburb (36.47%) and then eastern suburb wards (34.86%), matching with the proportion of cases in these wards during the study period. There was no significant difference in seropositivity among males and females and in different age groups.
Conclusions: Seropositivity is higher in slum areas than nonslum areas. It has reduced in slum areas and increased in nonslum areas as compared to findings of serosurveys 1 and 2. This explains the detection of a greater number of cases from nonslum areas in the second wave. The average seropositivity of 36.3% justifies the necessity of immunization on a wider scale in the city. Periodic serosurveys are required at fixed intervals to monitor the trend of infection and level of herd immunity.
Keywords: COVID-19; Chemiluminescence assay; IgG antibodies; seroprevalence; unlinked anonymous.
Copyright: © 2022 Indian Journal of Community Medicine.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
COVID-Kavach-Based Seropositivity in the General Population of Ahmedabad: Just Before the Start of the Vaccination for the Elderly in India.Cureus. 2022 Mar 1;14(3):e22759. doi: 10.7759/cureus.22759. eCollection 2022 Mar. Cureus. 2022. PMID: 35371875 Free PMC article.
-
Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city.J Family Med Prim Care. 2021 Jun;10(6):2363-2368. doi: 10.4103/jfmpc.jfmpc_2062_20. Epub 2021 Jul 2. J Family Med Prim Care. 2021. PMID: 34322439 Free PMC article.
-
Sentinel surveillance for HIV-1 among pregnant women in a developing country: 3 years' experience and comparison with a population serosurvey.AIDS. 1993 Jun;7(6):849-55. doi: 10.1097/00002030-199306000-00014. AIDS. 1993. PMID: 8363761
-
Seroprevalence of Immunoglobulin-G Antibody Among Confirm Cases of COVID-19.Cureus. 2021 Sep 14;13(9):e17956. doi: 10.7759/cureus.17956. eCollection 2021 Sep. Cureus. 2021. PMID: 34660144 Free PMC article.
-
Interventions to respond to COVID 19 pandemic in Mumbai and way forward.Indian J Tuberc. 2022 Apr;69(2):234-237. doi: 10.1016/j.ijtb.2021.04.013. Epub 2021 May 5. Indian J Tuberc. 2022. PMID: 35379407 Free PMC article. Review.
Cited by
-
A longitudinal study depicting persistence of COVID-19 antibodies after half a year using chemiluminescent microparticle immunoassay among healthcare workers and frontline workers in Mumbai, India's largest metropoli.J Family Med Prim Care. 2025 Mar;14(3):1009-1016. doi: 10.4103/jfmpc.jfmpc_1335_24. Epub 2025 Mar 25. J Family Med Prim Care. 2025. PMID: 40256063 Free PMC article.
References
-
- Indian Council of Medical research (2020 May 30) ICMR advises states to conduct Serosurvey to Measure Coronavirus Exposure in the population using IgG ELISA test. (Press release) [Last accessed on 2021 Feb 02]. Available from: https://www.icmr.gov.in/pdf/press_realease_files/ICMR_PR%20_IgG_Elisa_30... .
-
- [Last accessed on 2021 Feb 02]. Available from: https://www.mohfw.gov.in .
-
- [Last accessed on 2021 May 24]. Available form: https://www.portal.mcgm.gov.in .
-
- COVID-19 Serology Surveillance Strategy. [Last accessed on 2021 Feb 03]. Available from: https://www.cdc.gov .
-
- COVID-19: Union Health Ministry to Conduct another Sero-Surveillance Across India; 2020. [Last accessed on 2021 Feb 02]. Available from: https://www.aninews.in/news/national/general-news/covid-19-union-health-... .
LinkOut - more resources
Full Text Sources